Brief: Egetis Therapeutics Q1 Loss Widens To SEK 75.0 Mln

Egetis Therapeutics AB (publ)

03/05/2024 06:10

May 3 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * Q1 REVENUE MSEK 12.1 (6.8)
    * Q1 LOSS MSEK -75.0 (-74.9)

Source text for Eikon:  ID:nMFN3ggth8 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))